Paper Details

  1. Home
  2. Paper Details

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Author: CastellsXavier, EhimareUmonoibalo P, OtasowieJohn, SmithClare H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Attention deficit hyperactivity disorder (ADHD) is a condition that starts in childhood and can continue into adulthood. It affects children's daily lives, relationships, and school performance. While tricyclic antidepressants (TCAs) are sometimes used to treat ADHD symptoms in children, their effectiveness is not clear.
Paper Details　
Original Abstract of the Article :
Attention deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder of childhood onset, which may persist into adulthood. ADHD has a significant impact on a child's daily life, affecting relationships and academic performance. Its core symptoms include developmentally inappropri...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD006997.pub2

データ提供：米国国立医学図書館（NLM）

Tricyclic Antidepressants: A Second-Line Treatment for ADHD?

The world of childhood development is vast and fascinating, much like the endless dunes of a desert. ADHD, a neurodevelopmental disorder, presents a significant challenge for children, affecting their daily lives, relationships, and academic performance. This research delves into the potential benefits and limitations of using tricyclic antidepressants (TCAs) as a second-line treatment for ADHD in children and adolescents. The study employed a thorough review of existing literature to assess the effectiveness of TCAs in managing ADHD symptoms. The researchers discovered that while TCAs are sometimes used, their efficacy in reducing ADHD symptoms remains uncertain.

Uncertain Efficacy: A Need for Further Exploration

The study highlights the need for further research to definitively determine the effectiveness of TCAs in treating ADHD. While TCAs have been used in some cases, the lack of conclusive evidence raises concerns about their long-term benefits and potential side effects.

Navigating the Terrain of ADHD Treatment

Understanding the nuances of ADHD treatment is crucial for parents and caregivers. While TCAs may be considered in certain situations, it's essential to consult with a qualified healthcare professional to weigh the potential benefits and risks. Remember, a holistic approach to managing ADHD, including behavioral therapy, educational support, and lifestyle modifications, often proves most beneficial.

Dr. Camel's Conclusion

The use of tricyclic antidepressants for ADHD in children and adolescents remains a topic of ongoing research. While TCAs have been used in some cases, their efficacy is not yet established. It is essential to approach treatment with caution and seek professional guidance.

Date :
  1. Date Completed 2015-10-02
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

25238582

DOI: Digital Object Identifier

10.1002/14651858.CD006997.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.